Comparative study between Yav Amalaki churna and Nisha Amalaki churna in participants suffering from Prediabetes.

Efficacy of Yav Amalaki churna in comparision with Nisha Amalaki churna in management of Prediabetes :A randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089630

Enrollment

Registered

2025-06-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1]BMI 25 to 30 kg/m2 2]IDRS score more than 50. 3]People with age group - 35 yr to 49 yr in both sex. 4) Fasting blood glucose between 100 and 125 mg/dL. 5)Glucose tolerance between 140 and 199 mg/dl

Exclusion criteria

Exclusion criteria: 1]Those reporting prior use of medication to treat diabetes mellitus. 2) Had abnormal liver function studies; had symptoms of kidney failure or on renal dialysis; 3)Other major illness. 4) Gestational diabetes 5) Pregnancy or breastfeeding 6) Previously participate in any study of investigational drugs within 1month before this study 8] Uncontrolled hypertension

Design outcomes

Primary

Measure	Time frame
To compare the clinical effect of Yava Amalaki churna with Nisha Amalaki churna in management of Prediabetes.Timepoint: At the ened of 30 days.	—

Secondary

Measure	Time frame
To provide better drug of choice in management of Prediabetes.Timepoint: At the ened of 30 days.	—

Countries

India

Contacts

Public ContactDr Chetan Vishnu Pachmase

Shri Ayurved Mahavidyalaya Nagpur

drkyog@gmail.com9673906923

Outcome results